| 1 | Vertex Pharmaceuticals IncorporatedVRTX | $132.8B | $523.93 |
| 2 | Regeneron Pharmaceuticals, Inc.REGN | $82.9B | $805.02 |
| 3 | Moderna, Inc.MRNA | $79.9B | $200.10 |
| 4 | Revolution Medicines, Inc.RVMD | $40.1B | $186.99 |
| 5 | Alnylam Pharmaceuticals, Inc.ALNY | $30.0B | $224.03 |
| 6 | Roivant Sciences Ltd.ROIV | $26.4B | $36.49 |
| 7 | United Therapeutics CorporationUTHR | $25.2B | $587.50 |
| 8 | Incyte CorporationINCY | $23.5B | $115.71 |
| 9 | Insmed IncorporatedINSM | $20.4B | $93.39 |
| 10 | Exelixis, Inc.EXEL | $16.2B | $64.53 |
| 11 | Neurocrine Biosciences, Inc.NBIX | $14.5B | $142.70 |
| 12 | Halozyme Therapeutics, Inc.HALO | $14.3B | $125.63 |
| 13 | Jazz Pharmaceuticals plcJAZZ | $13.9B | $214.00 |
| 14 | BridgeBio Pharma, Inc.BBIO | $13.4B | $68.56 |
| 15 | Summit Therapeutics Inc.SMMT | $12.3B | $15.47 |
| 16 | Bio-Techne CorporationTECH | $11.4B | $72.55 |
| 17 | BioMarin Pharmaceutical Inc.BMRN | $10.8B | $55.95 |
| 18 | Madrigal Pharmaceuticals, Inc.MDGL | $10.0B | $434.24 |
| 19 | Vaxcyte, Inc.PCVX | $9.5B | $60.43 |
| 20 | 10x Genomics, Inc.TXG | $9.3B | $71.55 |
| 21 | Krystal Biotech, Inc.KRYS | $9.2B | $311.50 |
| 22 | Twist Bioscience CorporationTWST | $9.2B | $139.92 |
| 23 | Kymera Therapeutics, Inc.KYMR | $9.1B | $110.76 |
| 24 | Caris Life Sciences, Inc.CAI | $9.0B | $32.00 |
| 25 | Protagonist Therapeutics, Inc.PTGX | $9.0B | $138.43 |
| 26 | ImmunityBio, Inc.IBRX | $8.7B | $8.22 |
| 27 | Cytokinetics, IncorporatedCYTK | $8.5B | $61.23 |
| 28 | Apogee Therapeutics, Inc.APGE | $8.4B | $135.07 |
| 29 | Spyre Therapeutics, Inc.SYRE | $8.3B | $90.33 |
| 30 | TG Therapeutics, Inc.TGTX | $8.3B | $54.17 |
| 31 | Arrowhead Pharmaceuticals, Inc.ARWR | $8.2B | $58.02 |
| 32 | Axsome Therapeutics, Inc.AXSM | $7.6B | $145.04 |
| 33 | Ionis Pharmaceuticals, Inc.IONS | $7.1B | $42.93 |
| 34 | Praxis Precision Medicines, Inc.PRAX | $7.1B | $252.96 |
| 35 | Iovance Biotherapeutics, Inc.IOVA | $6.4B | $14.09 |
| 36 | Rhythm Pharmaceuticals, Inc.RYTM | $6.1B | $89.27 |
| 37 | Ligand Pharmaceuticals IncorporatedLGND | $6.1B | $303.53 |
| 38 | Immunovant, Inc.IMVT | $5.9B | $28.41 |
| 39 | Veradermics, IncorporatedMANE | $5.8B | $138.78 |
| 40 | Kodiak Sciences Inc.KOD | $5.5B | $87.63 |
| 41 | CG Oncology Inc.CGON | $5.5B | $61.71 |
| 42 | Cogent Biosciences, Inc.COGT | $5.4B | $31.21 |
| 43 | Oruka Therapeutics, Inc.ORKA | $5.3B | $80.15 |
| 44 | Mirum Pharmaceuticals, Inc.MIRM | $5.2B | $80.39 |
| 45 | PTC Therapeutics, Inc.PTCT | $5.1B | $60.59 |
| 46 | Scholar Rock Holding CorporationSRRK | $5.1B | $41.49 |
| 47 | Erasca, Inc.ERAS | $5.0B | $14.39 |
| 48 | Definium Therapeutics, Inc.DFTX | $4.8B | $35.67 |
| 49 | CRISPR Therapeutics AGCRSP | $4.8B | $49.39 |
| 50 | Travere Therapeutics, Inc.TVTX | $4.7B | $50.08 |
| 51 | Dianthus Therapeutics, Inc.DNTH | $4.3B | $76.78 |
| 52 | Edgewise Therapeutics, Inc.EWTX | $4.2B | $39.31 |
| 53 | Adaptive Biotechnologies CorporationADPT | $4.1B | $25.51 |
| 54 | Relay Therapeutics, Inc.RLAY | $4.0B | $18.18 |
| 55 | Tango Therapeutics, Inc.TNGX | $3.9B | $23.34 |
| 56 | Arcutis Biotherapeutics, Inc.ARQT | $3.9B | $31.20 |
| 57 | Xenon Pharmaceuticals Inc.XENE | $3.4B | $35.34 |
| 58 | Amylyx Pharmaceuticals, Inc.AMLX | $3.4B | $27.20 |
| 59 | Acadia Pharmaceuticals Inc.ACAD | $3.4B | $19.73 |
| 60 | IDEAYA Biosciences, Inc.IDYA | $3.3B | $34.71 |
| 61 | Celcuity Inc.CELC | $3.2B | $65.25 |
| 62 | Tarsus Pharmaceuticals, Inc.TARS | $3.2B | $68.20 |
| 63 | Viking Therapeutics, Inc.VKTX | $3.1B | $24.40 |
| 64 | Enliven Therapeutics, Inc.ELVN | $3.0B | $41.52 |
| 65 | Parabilis Medicines, Inc.PBLS | $3.0B | $24.44 |
| 66 | Denali Therapeutics Inc.DNLI | $2.9B | $18.41 |
| 67 | Dyne Therapeutics, Inc.DYN | $2.9B | $15.62 |
| 68 | Disc Medicine, Inc.IRON | $2.9B | $74.51 |
| 69 | Nurix Therapeutics, Inc.NRIX | $2.8B | $25.34 |
| 70 | Viridian Therapeutics, Inc.VRDN | $2.5B | $22.37 |
| 71 | Beam Therapeutics Inc.BEAM | $2.5B | $24.05 |
| 72 | ADMA Biologics, Inc.ADMA | $2.4B | $10.68 |
| 73 | MBX Biosciences, Inc. Common StockMBX | $2.3B | $48.50 |
| 74 | Arcus Biosciences, Inc.RCUS | $2.3B | $18.54 |
| 75 | SELLAS Life Sciences Group, Inc.SLS | $2.3B | $11.54 |
| 76 | Celldex Therapeutics, Inc.CLDX | $2.3B | $29.25 |
| 77 | Fortrea Holdings Inc.FTRE | $2.2B | $23.63 |
| 78 | Aurinia Pharmaceuticals Inc.AUPH | $2.2B | $16.86 |
| 79 | Precigen, Inc.PGEN | $2.2B | $6.19 |
| 80 | Agios Pharmaceuticals, Inc.AGIO | $2.2B | $37.00 |
| 81 | Vericel CorporationVCEL | $2.2B | $42.53 |
| 82 | Alamar Biosciences, Inc.ALMR | $2.1B | $30.69 |
| 83 | Immunome, Inc.IMNM | $2.1B | $17.99 |
| 84 | Harmony Biosciences Holdings, Inc.HRMY | $2.1B | $36.13 |
| 85 | Biohaven Ltd.BHVN | $2.1B | $13.88 |
| 86 | Maravai LifeSciences Holdings, Inc.MRVI | $2.1B | $7.32 |
| 87 | Zymeworks Inc.ZYME | $2.0B | $28.22 |
| 88 | Vera Therapeutics, Inc.VERA | $2.0B | $27.99 |
| 89 | Recursion Pharmaceuticals, Inc.RXRX | $2.0B | $3.70 |
| 90 | BioCryst Pharmaceuticals, Inc.BCRX | $2.0B | $7.65 |
| 91 | Septerna IncSEPN | $1.9B | $40.41 |
| 92 | Sarepta Therapeutics, Inc.SRPT | $1.9B | $17.73 |
| 93 | Xencor, Inc.XNCR | $1.9B | $25.18 |
| 94 | Xeris Biopharma Holdings, Inc.XERS | $1.9B | $10.20 |
| 95 | Mineralys Therapeutics, Inc.MLYS | $1.8B | $20.55 |
| 96 | Palvella Therapeutics, Inc.PVLA | $1.8B | $125.10 |
| 97 | Trevi Therapeutics, Inc.TRVI | $1.8B | $12.61 |
| 98 | Vir Biotechnology, Inc.VIR | $1.8B | $10.57 |
| 99 | Zenas BioPharma, Inc.ZBIO | $1.8B | $26.87 |
| 100 | Maze Therapeutics, Inc.MAZE | $1.7B | $31.01 |
| 101 | UroGen Pharma Ltd.URGN | $1.7B | $34.49 |
| 102 | Kailera Therapeutics, Inc.KLRA | $1.7B | $12.85 |
| 103 | Stoke Therapeutics, Inc.STOK | $1.6B | $25.04 |
| 104 | Hemab Therapeutics Holdings, Inc. Common StockCOAG | $1.6B | $34.40 |
| 105 | Nuvation Bio Inc.NUVB | $1.6B | $4.57 |
| 106 | Novavax, Inc.NVAX | $1.6B | $9.70 |
| 107 | Generate Biomedicines, Inc.GENB | $1.6B | $12.41 |
| 108 | Absci CorporationABSI | $1.6B | $9.18 |
| 109 | First Tracks Biotherapeutics IncTRAX | $1.6B | $44.05 |
| 110 | Intellia Therapeutics, Inc.NTLA | $1.6B | $11.21 |
| 111 | Ultragenyx Pharmaceutical Inc.RARE | $1.5B | $15.65 |
| 112 | Innoviva, Inc.INVA | $1.5B | $20.66 |
| 113 | AnaptysBio, Inc.ANAB | $1.5B | $48.73 |
| 114 | Ocular Therapeutix, Inc.OCUL | $1.4B | $6.50 |
| 115 | Inhibrx Biosciences Inc.INBX | $1.4B | $93.38 |
| 116 | ORIC Pharmaceuticals, Inc.ORIC | $1.4B | $13.17 |
| 117 | Damora Therapeutics, Inc.DMRA | $1.3B | $21.09 |
| 118 | Taysha Gene Therapies, Inc.TSHA | $1.3B | $3.96 |
| 119 | LB Pharmaceuticals Inc Common StockLBRX | $1.2B | $38.73 |
| 120 | Rapport Therapeutics, Inc. Common StockRAPP | $1.2B | $25.93 |
| 121 | Tyra Biosciences, Inc.TYRA | $1.2B | $20.45 |
| 122 | Omeros CorporationOMER | $1.2B | $16.57 |
| 123 | Syndax Pharmaceuticals, Inc.SNDX | $1.2B | $13.40 |
| 124 | Avalyn Pharma Inc. Common StockAVLN | $1.2B | $26.04 |
| 125 | Kardigan, Inc.KARD | $1.1B | $12.80 |
| 126 | Bicara Therapeutics Inc. Common StockBCAX | $1.1B | $17.07 |
| 127 | Seaport Therapeutics, Inc. Common StockSPTX | $1.1B | $20.61 |
| 128 | Replimune Group, Inc.REPL | $1.1B | $11.46 |
| 129 | Nektar TherapeuticsNKTR | $1.1B | $37.22 |
| 130 | ArriVent BioPharma, Inc.AVBP | $1.0B | $21.00 |
| 131 | MannKind CorporationMNKD | $1.0B | $3.19 |
| 132 | Janux Therapeutics, Inc.JANX | $1.0B | $16.66 |
| 133 | Vor Biopharma Inc.VOR | $989.4M | $18.26 |
| 134 | SpyGlass Pharma, Inc. Common StockSGP | $952.6M | $28.48 |
| 135 | Odyssey Therapeutics, Inc.ODTX | $941.9M | $19.60 |
| 136 | Jade Biosciences, Inc.JBIO | $927.9M | $14.59 |
| 137 | Monte Rosa Therapeutics, Inc.GLUE | $924.8M | $10.84 |
| 138 | Verastem, Inc.VSTM | $909.3M | $10.04 |
| 139 | Rigel Pharmaceuticals, Inc.RIGL | $899.1M | $48.13 |
| 140 | Corvus Pharmaceuticals, Inc.CRVS | $885.8M | $10.53 |
| 141 | MeiraGTx Holdings plcMGTX | $884.6M | $9.21 |
| 142 | Theravance Biopharma IncTBPH | $884.2M | $17.03 |
| 143 | Cullinan Therapeutics, Inc.CGEM | $883.2M | $14.37 |
| 144 | Alumis Inc.ALMS | $877.6M | $6.78 |
| 145 | Savara Inc.SVRA | $867.0M | $4.22 |
| 146 | Alto Neuroscience, Inc.ANRO | $862.1M | $21.97 |
| 147 | Kura Oncology, Inc.KURA | $854.9M | $9.61 |
| 148 | Aktis Oncology, Inc.AKTS | $845.4M | $15.73 |
| 149 | Arbutus Biopharma CorpABUS | $832.0M | $4.20 |
| 150 | Apnimed, Inc.APMD | $790.6M | $18.99 |
| 151 | Ardelyx, Inc.ARDX | $767.5M | $3.08 |
| 152 | Geron CorporationGERN | $719.6M | $1.12 |
| 153 | Sana Biotechnology, Inc.SANA | $697.5M | $2.33 |
| 154 | OmniAb, Inc.OABI | $677.5M | $4.66 |
| 155 | Immix Biopharma, Inc.IMMX | $675.7M | $8.15 |
| 156 | Ginkgo Bioworks Holdings, Inc.DNA | $672.7M | $9.99 |
| 157 | Achieve Life Sciences, Inc.ACHV | $667.8M | $6.49 |
| 158 | Prime Medicine, Inc.PRME | $665.7M | $3.67 |
| 159 | Nuvectis Pharma, Inc.NVCT | $654.5M | $20.05 |
| 160 | Aura Biosciences, Inc.AURA | $653.3M | $6.30 |
| 161 | Design Therapeutics, Inc.DSGN | $640.8M | $10.24 |
| 162 | Solid Biosciences Inc.SLDB | $634.8M | $5.92 |
| 163 | Lexicon Pharmaceuticals, Inc.LXRX | $631.8M | $1.42 |
| 164 | Wave Life Sciences Ltd.WVE | $626.6M | $3.18 |
| 165 | Gyre Therapeutics, Inc.GYRE | $620.3M | $5.85 |
| 166 | Candel Therapeutics, Inc.CADL | $614.4M | $8.03 |
| 167 | Annexon, Inc.ANNX | $614.4M | $3.75 |
| 168 | CorMedix Inc.CRMD | $611.9M | $7.85 |
| 169 | 4D Molecular Therapeutics, Inc.FDMT | $596.6M | $10.80 |
| 170 | Climb Bio, Inc.CLYM | $585.3M | $10.19 |
| 171 | Zevra Therapeutics, Inc.ZVRA | $582.6M | $9.81 |
| 172 | MiMedx Group, Inc.MDXG | $569.9M | $3.91 |
| 173 | Puma Biotechnology, Inc.PBYI | $568.9M | $11.02 |
| 174 | Olema Pharmaceuticals, Inc.OLMA | $560.9M | $6.41 |
| 175 | Aclaris Therapeutics, Inc.ACRS | $552.0M | $3.75 |
| 176 | Shattuck Labs, Inc.STTK | $551.0M | $5.49 |
| 177 | Bright Minds Biosciences Inc.DRUG | $517.7M | $52.48 |
| 178 | CytomX Therapeutics, Inc.CTMX | $505.5M | $2.32 |
| 179 | Crescent Biopharma, Inc.CBIO | $476.2M | $12.82 |
| 180 | Monopar Therapeutics Inc.MNPR | $474.2M | $70.65 |
| 181 | Arvinas, Inc.ARVN | $471.0M | $7.30 |
| 182 | Phathom Pharmaceuticals, Inc.PHAT | $464.4M | $5.74 |
| 183 | REGENXBIO Inc.RGNX | $441.0M | $6.68 |
| 184 | Allogene Therapeutics, Inc.ALLO | $431.9M | $1.25 |
| 185 | Ovid Therapeutics Inc.OVID | $421.8M | $2.16 |
| 186 | Prothena Corporation plcPRTA | $421.0M | $8.20 |
| 187 | Altimmune, Inc.ALT | $412.4M | $2.12 |
| 188 | Nautilus Biotechnolgy, Inc.NAUT | $412.3M | $3.24 |
| 189 | Assembly Biosciences, Inc.ASMB | $404.0M | $19.84 |
| 190 | ARS Pharmaceuticals, Inc.SPRY | $400.8M | $4.03 |
| 191 | Eikon Therapeutics, Inc. Common StockEIKN | $393.0M | $7.26 |
| 192 | Tectonic Therapeutic, Inc.TECX | $392.4M | $20.07 |
| 193 | C4 Therapeutics, Inc.CCCC | $376.5M | $3.06 |
| 194 | Rezolute, Inc.RZLT | $372.9M | $3.86 |
| 195 | Neurogene Inc.NGNE | $372.1M | $23.55 |
| 196 | Avalo Therapeutics, Inc.AVTX | $371.7M | $6.93 |
| 197 | Editas Medicine, Inc.EDIT | $368.6M | $2.40 |
| 198 | Fennec Pharmaceuticals Inc.FENC | $353.5M | $10.08 |
| 199 | Relmada Therapeutics, Inc.RLMD | $348.8M | $3.27 |
| 200 | Capricor Therapeutics, Inc.CAPR | $343.4M | $5.93 |
| 201 | MapLight Therapeutics, Inc.MPLT | $339.7M | $7.97 |
| 202 | Enanta Pharmaceuticals, Inc.ENTA | $339.0M | $11.64 |
| 203 | Orchestra BioMed Holdings, Inc.OBIO | $336.0M | $5.59 |
| 204 | Kyverna Therapeutics, Inc.KYTX | $333.3M | $5.39 |
| 205 | Atea Pharmaceuticals, Inc.AVIR | $324.0M | $4.04 |
| 206 | X4 Pharmaceuticals, Inc.XFOR | $321.2M | $3.24 |
| 207 | Turn Therapeutics Inc.TTRX | $312.2M | $10.28 |
| 208 | Sagimet Biosciences Inc.SGMT | $312.1M | $9.58 |
| 209 | Benitec Biopharma Inc.BNTC | $301.7M | $8.65 |
| 210 | Artiva Biotherapeutics, Inc.ARTV | $300.7M | $6.15 |
| 211 | Opus Genetics, Inc.IRD | $288.7M | $3.47 |
| 212 | Agenus Inc.AGEN | $285.9M | $6.33 |
| 213 | Fulcrum Therapeutics, Inc.FULC | $280.8M | $3.68 |
| 214 | Arcturus Therapeutics Holdings Inc.ARCT | $279.7M | $9.84 |
| 215 | Contineum Therapeutics, Inc.CTNM | $273.9M | $8.31 |
| 216 | Century Therapeutics, Inc.IPSC | $264.4M | $1.46 |
| 217 | SAB Biotherapeutics, Inc.SABS | $258.4M | $2.84 |
| 218 | Q32 Bio Inc.QTTB | $257.5M | $8.65 |
| 219 | Lineage Cell Therapeutics, Inc.LCTX | $252.9M | $1.00 |
| 220 | Abeona Therapeutics Inc.ABEO | $251.6M | $4.40 |
| 221 | Rocket Pharmaceuticals, Inc.RCKT | $251.4M | $2.29 |
| 222 | Ocugen, Inc.OCGN | $250.8M | $0.74 |
| 223 | Scribe Therapeutics Inc.SCTX | $249.3M | $15.41 |
| 224 | Cabaletta Bio, Inc.CABA | $249.2M | $1.47 |
| 225 | Fate Therapeutics, Inc.FATE | $245.9M | $2.11 |
| 226 | Larimar Therapeutics, Inc.LRMR | $244.1M | $2.35 |
| 227 | Vanda Pharmaceuticals Inc.VNDA | $242.5M | $4.01 |
| 228 | Immuneering CorporationIMRX | $241.3M | $3.73 |
| 229 | Greenwich LifeSciences, Inc.GLSI | $235.3M | $16.03 |
| 230 | Lyell Immunopharma, Inc.LYEL | $230.1M | $9.39 |
| 231 | Lexeo Therapeutics, Inc. Common StockLXEO | $229.8M | $2.80 |
| 232 | Keros Therapeutics, Inc.KROS | $223.7M | $11.28 |
| 233 | Inhibikase Therapeutics, Inc.IKT | $221.9M | $1.59 |
| 234 | BridgeBio Oncology Therapeutics Inc.BBOT | $213.3M | $2.66 |
| 235 | Prelude Therapeutics IncorporatedPRLD | $210.1M | $3.63 |
| 236 | Galectin Therapeutics Inc.GALT | $210.1M | $3.19 |
| 237 | CAMP4 Therapeutics CorporationCAMP | $207.1M | $3.30 |
| 238 | Alector, Inc.ALEC | $204.3M | $1.83 |
| 239 | Niagen Bioscience IncNAGE | $192.3M | $2.43 |
| 240 | BioAge Labs Inc.BIOA | $192.0M | $5.10 |
| 241 | Surrozen, Inc.SRZN | $190.5M | $25.48 |
| 242 | Cartesian Therapeutics, Inc.RNAC | $187.0M | $6.18 |
| 243 | Eledon Pharmaceuticals, Inc.ELDN | $186.9M | $2.30 |
| 244 | Evommune, Inc.EVMN | $185.1M | $5.10 |
| 245 | ADC Therapeutics S.A.ADCT | $183.8M | $1.44 |
| 246 | Precision BioSciences, Inc.DTIL | $183.3M | $6.64 |
| 247 | Whitehawk Therapeutics IncWHWK | $183.0M | $3.21 |
| 248 | Invivyd, Inc.IVVD | $180.8M | $0.61 |
| 249 | Korro Bio, Inc.KRRO | $176.4M | $11.98 |
| 250 | PepGen Inc.PEPG | $174.3M | $2.52 |
| 251 | Entrada Therapeutics, Inc.TRDA | $171.7M | $4.41 |
| 252 | Sionna Therapeutics, Inc.SION | $162.5M | $3.60 |
| 253 | ALX Oncology Holdings Inc.ALXO | $161.8M | $1.17 |
| 254 | Zentalis Pharmaceuticals, Inc.ZNTL | $157.3M | $2.21 |
| 255 | Akebia Therapeutics, Inc.AKBA | $157.1M | $0.57 |
| 256 | Coherus Oncology, Inc.CHRS | $156.0M | $1.01 |
| 257 | MediWound Ltd.MDWD | $154.9M | $12.00 |
| 258 | Sutro Biopharma, Inc.STRO | $154.7M | $9.33 |
| 259 | Upstream Bio, Inc.UPB | $150.1M | $2.74 |
| 260 | Canton Strategic Holdings IncCNTN | $148.2M | $1.86 |
| 261 | MaxCyte, Inc.MXCT | $144.5M | $1.40 |
| 262 | MacroGenics, Inc.MGNX | $143.3M | $2.25 |
| 263 | Acumen Pharmaceuticals, Inc.ABOS | $143.2M | $1.98 |
| 264 | Atrium Therapeutics, Inc.RNA | $140.3M | $8.20 |
| 265 | Codexis, Inc.CDXS | $140.2M | $1.28 |
| 266 | TuHURA Biosciences, Inc.HURA | $138.9M | $2.18 |
| 267 | Protara Therapeutics, Inc.TARA | $137.7M | $2.33 |
| 268 | Compass Therapeutics, Inc.CMPX | $137.0M | $0.76 |
| 269 | Cue Biopharma, Inc.CUE | $135.6M | $18.66 |
| 270 | Armata Pharmaceuticals, Inc.ARMP | $135.3M | $3.64 |
| 271 | AN2 Therapeutics, Inc.ANTX | $134.0M | $3.55 |
| 272 | Spruce Biosciences, Inc.SPRB | $129.8M | $45.15 |
| 273 | Nkarta, Inc.NKTX | $128.2M | $1.79 |
| 274 | Outlook Therapeutics, Inc.OTLK | $126.4M | $0.52 |
| 275 | Anavex Life Sciences Corp.AVXL | $123.3M | $1.33 |
| 276 | Humacyte, Inc.HUMA | $121.0M | $0.44 |
| 277 | Foghorn Therapeutics Inc.FHTX | $118.8M | $2.00 |
| 278 | Minerva Neurosciences, Inc.NERV | $109.8M | $2.30 |
| 279 | Seer, Inc.SEER | $109.1M | $1.97 |
| 280 | NRx Pharmaceuticals, Inc.NRXP | $107.8M | $2.49 |
| 281 | Cibus, Inc.CBUS | $107.8M | $1.41 |
| 282 | Black Diamond Therapeutics, Inc.BDTX | $107.7M | $1.88 |
| 283 | Voyager Therapeutics, Inc.VYGR | $107.2M | $1.74 |
| 284 | Unicycive Therapeutics, Inc.UNCY | $106.6M | $3.89 |
| 285 | Pyxis Oncology, Inc.PYXS | $106.4M | $1.68 |
| 286 | Anixa Biosciences, Inc.ANIX | $103.9M | $2.99 |
| 287 | OnKure Therapeutics, Inc.OKUR | $102.1M | $2.52 |
| 288 | Immunic, Inc.IMUX | $101.1M | $7.41 |
| 289 | vTv Therapeutics Inc.VTVT | $101.0M | $25.55 |
| 290 | Vivani Medical, Inc.VANI | $100.1M | $1.11 |
| 291 | LENZ Therapeutics, Inc.LENZ | $99.3M | $3.16 |
| 292 | Neonc Technologies Holdings, Inc.NTHI | $94.2M | $3.27 |
| 293 | ImmuCell CorporationICCC | $93.1M | $10.25 |
| 294 | NeurAxis, Inc.NRXS | $92.9M | $7.40 |
| 295 | Coya Therapeutics, Inc.COYA | $92.4M | $3.94 |
| 296 | Polaryx Therapeutics, Inc. Common StockPLYX | $92.2M | $1.85 |
| 297 | Genelux CorporationGNLX | $90.5M | $2.00 |
| 298 | Tonix Pharmaceuticals Holding Corp.TNXP | $88.7M | $5.17 |
| 299 | Rallybio CorporationRLYB | $88.4M | $16.64 |
| 300 | Tenaya Therapeutics, Inc.TNYA | $87.2M | $0.39 |
| 301 | Atara Biotherapeutics, Inc.ATRA | $86.2M | $8.59 |
| 302 | Corbus Pharmaceuticals Holdings, Inc.CRBP | $78.3M | $4.05 |
| 303 | Equillium, Inc.EQ | $78.0M | $1.23 |
| 304 | Acrivon Therapeutics, Inc. Common StockACRV | $74.1M | $1.73 |
| 305 | Cingulate Inc.CING | $72.4M | $4.98 |
| 306 | Telomir Pharmaceuticals, Inc. Common StockTELO | $71.8M | $0.98 |
| 307 | Neumora Therapeutics, Inc. Common StockNMRA | $71.3M | $0.38 |
| 308 | MAIA Biotechnology, Inc.MAIA | $71.0M | $1.15 |
| 309 | Cardiff Oncology, Inc.CRDF | $70.6M | $0.91 |
| 310 | Nutriband Inc.NTRB | $70.0M | $5.76 |
| 311 | Cognition Therapeutics, Inc.CGTX | $68.4M | $0.72 |
| 312 | PMV Pharmaceuticals, Inc.PMVP | $67.7M | $1.27 |
| 313 | Champions Oncology, Inc.CSBR | $65.7M | $4.72 |
| 314 | Pelthos Therapeutics Inc.PTHS | $65.1M | $17.00 |
| 315 | Spero Therapeutics, Inc.SPRO | $64.6M | $1.11 |
| 316 | Fortress Biotech, Inc.FBIO | $64.4M | $1.93 |
| 317 | Inovio Pharmaceuticals, Inc.INO | $62.0M | $0.90 |
| 318 | Verrica Pharmaceuticals Inc.VRCA | $60.6M | $3.53 |
| 319 | Gossamer Bio, Inc.GOSS | $58.7M | $9.61 |
| 320 | OS Therapies IncorporatedOSTX | $58.5M | $1.25 |
| 321 | RenovoRx, Inc.RNXT | $58.2M | $1.29 |
| 322 | Heron Therapeutics, Inc.HRTX | $57.5M | $0.30 |
| 323 | Caribou Biosciences, Inc.CRBU | $57.1M | $0.53 |
| 324 | MiNK Therapeutics, Inc.INKT | $54.7M | $10.71 |
| 325 | Boundless Bio, Inc.BOLD | $53.7M | $2.36 |
| 326 | Pliant Therapeutics, Inc.PLRX | $53.5M | $0.86 |
| 327 | Xilio Therapeutics, Inc.XLO | $49.8M | $7.57 |
| 328 | ImageneBio IncIMA | $47.9M | $4.22 |
| 329 | Tenax Therapeutics, Inc.TENX | $45.6M | $1.72 |
| 330 | Eloxx Pharmaceuticals, Inc.ELOX | $44.0M | $12.80 |
| 331 | Biomea Fusion, Inc.BMEA | $43.4M | $0.60 |
| 332 | Annovis Bio, Inc.ANVS | $42.6M | $1.00 |
| 333 | Kalaris Therapeutics IncKLRS | $40.8M | $1.87 |
| 334 | INmune Bio, Inc.INMB | $40.5M | $1.46 |
| 335 | Instil Bio, Inc.TIL | $39.6M | $5.84 |
| 336 | Rani Therapeutics Holdings, Inc.RANI | $39.6M | $0.61 |
| 337 | Aldeyra TheALDX | $39.2M | $0.65 |
| 338 | Adicet Bio, Inc.ACET | $37.4M | $3.99 |
| 339 | eXoZymes, Inc.EXOZ | $37.1M | $4.00 |
| 340 | EyePoint Pharmaceuticals, Inc.EYPT | $33.9M | $0.40 |
| 341 | Aardvark Therapeutics, Inc. Common StockAARD | $30.4M | $1.39 |
| 342 | Seres Therapeutics, Inc.MCRB | $20.8M | $2.09 |
| 343 | Fractyl Health, Inc.GUTS | $14.3M | $1.08 |
